Company overview
Basic information
Company name
Express Heroes, UAB
Company code
305019406
VAT code
LT100012204014
Registered address
Kaunas, Pramonės pr. 13, LT-51327
Registration date
2019-02-11
Company age: 7 y. 8 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://expressheroes.eu/lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Activities of freight and forwarding agents
Ownership form
Privately owned with foreign capital
Express Heroes UAB
Company code: 305019406
Address: Kaunas, Pramonės pr. 13, LT-51327
VAT code: LT100012204014
Description
This description was generated by artificial intelligence.
Express Heroes, UAB (company code 305019406) is an operational private limited liability company registered in 2019. It belongs to the sector of national private non-financial companies and is privately owned, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and capital from foreign investors also included. Governance is CEO only. The company operates under EVRK code H.52.26.20, Activities of freight agents and forwarders, and is located in Kaunas, Pramones pr. 13, Kauno m. sav., Kauno apskr. Financially, in 2025 it generated EUR 57.98 million in revenue, up 5.9% year on year, while net profit was EUR 103.0 thousand and the profit margin was 0.2%. Total assets stood at EUR 11.58 million, equity at EUR 3.94 million, and liabilities at EUR 8.17 million. On the staffing side, the company averaged 78 employees so far in 2026, down 2.5% year on year, while the average monthly wage reached EUR 3,757.37, up 4.2% year on year.
Download a detailed company report
Make confident decisions with all the information about Express Heroes, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.